Terms ending in 2043
Roche Sequencing Solutions, Inc.
Every in-force patent on Roche Sequencing Solutions, Inc.'s record whose computed term ends in 2043, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 12,596,098 | Device for Volume Coupling in Epitachophoresis In force · High confidence | Roche Sequencing Solutions, Inc. | In force | High confidence | |
| US 12,467,085 | High Accuracy Nanopore-Based Single Molecule Sequencing by Synthesis with Tagged Nucleotides In force · High confidence | Roche Sequencing Solutions, Inc. | In force | High confidence | |
| US 12,590,328 | Targeted Depletion of Non-Target Library Molecules Using Poison Primers During Target Capture of Next-Generation Sequencing Libraries In force · High confidence | Roche Sequencing Solutions, Inc. | In force | High confidence | |
| US 12,460,253 | Spatially Oriented Quantum Barcoding of Cellular Targets In force · High confidence | Roche Sequencing Solutions, Inc. | In force | High confidence | |
| US 12,571,059 | Compositions and Methods for Detection of Epstein Barr Virus (EBV) In force · High confidence | Roche Sequencing Solutions, Inc. | In force | High confidence | |
| US 12,595,591 | Peptide Libraries Having Enhanced Subsequence Diversity and Methods for Use Thereof In force · High confidence | Roche Sequencing Solutions, Inc. | In force | High confidence |
6 of 6 patents shown. Soonest term end first, then patent number.
Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.